Elevate

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded GLP-1 (semaglutide-type)Compounded · not FDA-approved
• Compounded GLP-1/GIP (tirzepatide-type)Compounded · not FDA-approved

What they publish

Elevate publishes 0 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Not publicly disclosed on the pages we captured.

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

$200 discount advertised at capture

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Both product lines published were compounded; no FDA-approved route appeared on the page we captured.
• A large advertised discount without a clearly published standard price makes the real ongoing cost hard to establish before starting an intake.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Establish the standard ongoing price the $200 discount applies against.
• Ask which pharmacy compounds the products and whether it is a 503A or 503B facility.
• Ask what clinical assessment and follow-up is included.